Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1975-12-11
1977-04-05
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 92, A61K 3900, A61K 3902, A61K 3912, A61K 4700
Patent
active
040162524
ABSTRACT:
An improved aqueous gel of calcium phosphate, useful for preparation of adsorbed vaccines, prepared by contacting an antigen with an aqueous gel obtained by reacting an aqueous solution of dibasic sodium phosphate with an aqueous solution of calcium chloride, wherein the calcium chloride solution is poured as rapidly as possible, within less than 3 minutes, into said phosphate solution, in a proportion substantially equal to 1 mol PO.sub.4 HNa.sub.2 for 1 mol CaCl.sub.2, under stirring; the mixture thus obtained is still stirred while its pH is adjusted to a value very near 7, and the gel formed is subsequently decanted and washed. The gel is composed of calcium and phosphate ions in proportions such that the ratio Ca/P is 1.62 to 1.85, and exhibits a settling rate of 1 to 20 mm in 10 minutes at 20.degree. C when containing 0.07 atoms Ca per liter.
REFERENCES:
patent: 2605229 (1952-07-01), Marcus
patent: 2967802 (1961-01-01), Towey et al.
patent: 3027229 (1962-03-01), Towey et al.
patent: 3608071 (1971-09-01), Relyveld
patent: 3925545 (1975-12-01), Relyveld
Institut Pasteur
Rose Shep K.
LandOfFree
Calcium phosphate gel for adsorbing vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium phosphate gel for adsorbing vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium phosphate gel for adsorbing vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2266201